You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 25, 2024

Details for Patent: 5,223,510


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,223,510
Title: Alkylaminoalkyl derivatives of benzofuran, benzothiophene, indole and indolizine, process for their preparation and compositions containing them
Abstract:The subject of the invention is benzofuran, benzothiophene, indole or indolizine compounds of general formula: ##STR1## in which: Het represents one of the groups: ##STR2## in which T,T' and T"represent particularly a group: ##STR3## R and R.sub.a, identical or different, represent X represent --O-- or --S-- Y represents a radical ##STR4## These compounds are useful as medecines particularly for the treatment of pathological syndroms of the cardio-vascular system.
Inventor(s): Gubin; Jean (Brussels, BE), Chatelain; Pierre (Brussels, BE), Lucchetti; Jean (Chastre, BE), Rosseels; Gilbert (Wemmel, BE), Inion; Henri (Wemmel, BE)
Assignee: Sanofi (Paris, FR)
Application Number:07/736,580
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 5,223,510

Introduction

United States Patent 5,223,510, titled "Alkylaminoalkyl derivatives of benzofuran, benzothiophene, indole and indolizine, process for their preparation and compositions containing them," is a patent that covers a range of chemical compounds and their applications. Here, we will delve into the key components of this patent, including its scope, claims, and the broader patent landscape.

Patent Structure and Components

Document Number and Type

The patent number, US5223510A, indicates that this is a U.S. patent. The "A" suffix signifies that it is the first publication of the patent application[1].

Title and Abstract

The title of the patent is descriptive, highlighting the specific chemical derivatives it covers. The abstract provides a brief, non-technical description of the invention, which includes the preparation and use of these compounds, particularly in the treatment of cardiovascular system pathological syndromes[4].

Field of Search and Classifications

The patent is classified under specific categories, such as the International Patent Classification (IPC) and the U.S. National Classification system. These classifications help in identifying the technical field to which the invention pertains and facilitate prior art searches[1].

Inventors, Applicants, and Assignees

The patent lists the inventors, the applicant who filed the patent application, and the assignee who owns the patent at the time of issuance. This information is crucial for understanding the ownership and rights associated with the patent[1].

Claims

Definition and Purpose

The claims section is a critical part of any patent, as it defines the scope of protection for the invention. The claims must be clear, distinct, and particularly point out the subject matter regarded as the invention by the applicant[2].

Claim Structure

For US5223510A, the claims would typically include independent and dependent claims. Independent claims stand alone and define the invention in broad terms, while dependent claims further limit the scope of the independent claims. Each claim must be read in the context of the full claim and the specification to understand the invention's scope[2].

Example of Claim Language

While the specific claims of US5223510A are not detailed here, they would likely describe the chemical structures, preparation methods, and uses of the alkylaminoalkyl derivatives. For instance, a claim might specify:

  • "A compound of formula I, wherein R represents a --SO2R' group and R' represents hydrogen."
  • "A pharmaceutical composition containing at least one compound of formula I and a suitable excipient or pharmaceutical vehicle."

Specification

Detailed Description

The specification provides a detailed written description of the invention, including the related prior art, descriptions of the drawings, how the invention solves a specific technical problem, and the preferred embodiment of the invention. It must be detailed enough so that anyone of ordinary skill in the same technical field can understand and replicate the invention[1].

Preparation Methods and Uses

For US5223510A, the specification would include methods for preparing the alkylaminoalkyl derivatives, their pharmacological properties, and their potential uses in treating cardiovascular diseases. It would also describe the pharmaceutical compositions and the dosages for human use[4].

Drawings and Illustrations

Technical Details

The drawings section contains black and white drawings that illustrate the technical details of the invention. While not explicitly mentioned for this patent, drawings could include chemical structures, synthesis pathways, or other relevant technical illustrations[1].

Patent Landscape

Patent Scope and Quality

The scope of a patent is a critical aspect of patent quality. Metrics such as independent claim length and count can be used to measure patent scope. Narrower claims are often associated with a higher probability of grant and a shorter examination process[3].

Litigation and Validity

Patent claims must be definite and clear to avoid issues of indefiniteness, which can lead to invalidation. The case of Maxell, Ltd. v. Amperex Technology Limited highlights the importance of clear claim language and the consequences of indefinite claims[2].

Industry Impact

Patents like US5223510A can significantly impact the pharmaceutical industry by providing exclusive rights to the inventors or assignees for a specified period. This can influence innovation, licensing, and litigation within the industry. For instance, the compounds described in this patent have shown promising pharmacological properties, which could lead to further research and development in cardiovascular treatments[4].

Key Takeaways

  • Clear Claims: The claims section is crucial and must be clear and distinct to define the scope of protection.
  • Detailed Specification: The specification must provide enough detail for someone skilled in the field to understand and replicate the invention.
  • Patent Scope: The scope of the patent, measured by metrics like claim length and count, can impact the patent's validity and examination process.
  • Industry Impact: Patents in the pharmaceutical sector can drive innovation and influence the development of new treatments.

FAQs

  1. What is the significance of the claims section in a patent? The claims section defines the scope of protection for the invention, making it a critical part of the patent.

  2. How does the specification section contribute to the patent? The specification provides a detailed written description of the invention, ensuring that it can be understood and replicated by those skilled in the field.

  3. What metrics are used to measure patent scope? Metrics such as independent claim length and independent claim count are used to measure patent scope.

  4. Why is claim clarity important? Claim clarity is essential to avoid issues of indefiniteness, which can lead to the invalidation of the patent.

  5. How can patents like US5223510A impact the pharmaceutical industry? Patents like US5223510A can drive innovation, influence licensing agreements, and affect litigation within the pharmaceutical industry.

Sources

  1. Guides.library.queensu.ca - How to Read a U.S. Patent - Patents and Designs - Research Guides
  2. CAFC.uscourts.gov - MAXELL, LTD. v. AMPEREX TECHNOLOGY LIMITED
  3. Hoover.org - Patent Claims and Patent Scope - Hoover Institution
  4. Google Patents - US5223510A - Alkylaminoalkyl derivatives of benzofuran, benzothiophene, indole and indolizine, process for their preparation and compositions containing them
  5. PubChem.ncbi.nlm.nih.gov - Alkylaminoalkyl derivatives of benzofuran, benzothiophene, indole ...

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 5,223,510

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 5,223,510

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France90 10036Aug 06, 1990

International Family Members for US Patent 5,223,510

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 145645 ⤷  Subscribe
Australia 648569 ⤷  Subscribe
Australia 8142891 ⤷  Subscribe
Brazil 9103354 ⤷  Subscribe
Canada 2047773 ⤷  Subscribe
Czechoslovakia 9102427 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.